Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes

NCT05386186 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT05386186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05386186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes
Lead sponsor
Peking University People's Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
January 1, 2022
Completion date
March 31, 2024
Enrollment
192 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, severe insulin deficient diabetes